Focusing on Quality for Parenteral Drug Manufacturing
Jul 23, 2013
By BioPharm International Editors
Susan Schniepp, vice-president of quality and regulatory affairs at Allergy Laboratories and co-chair of the program planning committee for the 2013 PDA/FDA Joint Regulatory Conference, discusses quality systems and related considerations in parenteral drug manufacturing.
Contract manufacturers are essential players that allow biopharmaceutical companies the flexibility to address fluctuating product demand and the ability to outsource projects that are not strategically critical..